Repligen | Stammkapital



Ordinary Share Capital Veränderung Datum
Agilent USD 3M 0 2025-04
Align Technology USD 72.48M 572K 2025-06
Bio Techne USD 156.76M 155.19M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Bruker USD 151.72M 149.92M 2025-06
Charles River Laboratories USD 49.21M 48.7M 2025-06
Danaher USD 715.9M 706.9M 2025-06
Dentsply International USD 199.3M 196.3M 2025-06
Exact Sciences USD 189.22M 187.33M 2025-06
General Electric Aerospace USD 1.06B 1.05B 2025-06
Henry Schein USD 121.9M 120.9M 2025-06
Illumina USD 154M 152M 2025-06
IQVIA Holdings USD 170M 167.42M 2025-06
Mettler Toledo International USD 20.6M 20.15M 2025-06
Myriad Genetics USD 900K 0 2025-03
Pfizer USD 5.68B 5.2B 2025-06
Repligen USD 562K 1000 2025-03
Revvity USD 117.87M 2.78M 2025-06
Standard Biotools USD 396K 6K 2024-12
Thermo Fisher Scientific USD 377.49M 66.51M 2025-06
Waters USD 59.51M 57.88M 2025-06
West Pharmaceutical Services USD 71.9M 53.1M 2025-06


Repligen Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.